Disclosure under Regulation 7(2) Read with Regulation 6(2) - Disclosure of SEBI (Prohibition of Insider Trading) Regulations, 2015 - Atibha Agriseeds Private Limited
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chemo Pharma Laboratories Ltd (BSE: 506365) disclosed a Form C under SEBI Insider Trading Regulations, reporting that its promoter, Atibha Agriseeds Private Limited, bought 48,781 equity shares worth approximately ₹48.78 lakh through a market purchase on BSE on 18 July 2025. This raised the promoter's stake in the company from 24.63% (3,69,500 shares) to 27.88% (4,18,281 shares). The disclosure was made by Ruchit Mehta, Director of Atibha Agriseeds and also Managing Director & CEO of Chemo Pharma. The transaction was a creeping acquisition by a post-open-offer promoter, executed on the open market with no derivatives involved.
Promoter buying on the open market is generally viewed as a confidence signal, suggesting insiders believe the stock is undervalued. With the promoter stake now at 27.88%, the company is moving further away from the minimum public shareholding concern zone, though the holding remains well below 50%, leaving the company with no controlling-promoter majority.